| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0963180114000589 |
| P698 | PubMed publication ID | 26059952 |
| P2093 | author name string | Bonnie Kaplan | |
| P2860 | cites work | Prescriptions, privacy, and the First Amendment | Q45785403 |
| Competition in the pharmaceutical industry: how do quality differences shape advertising strategies? | Q46086407 | ||
| Higher First Amendment hurdles for public health regulation. | Q46945498 | ||
| The Right to Privacy | Q54165897 | ||
| Currents in contemporary bioethics. Access to sensitive information in segmented electronic health records | Q58664983 | ||
| Betrayal of confidence in the Court of Appeal | Q79817732 | ||
| Ownership of medical information | Q83550710 | ||
| Challenges in ethics, safety, best practices, and oversight regarding HIT vendors, their customers, and patients: a report of an AMIA special task force | Q24625329 | ||
| Sorrell v. IMS Health: issues and opportunities for informaticians | Q28709485 | ||
| HEALTH RESEARCH, DATA PROTECTION, AND THE PUBLIC INTEREST IN NOTIFICATION | Q28816167 | ||
| Prescription data mining and the protection of patients' interests | Q33571838 | ||
| Restrictions on the use of prescribing data for drug promotion | Q33980473 | ||
| Marketing pharmaceuticals: a constitutional right to sell prescriber-identified data? | Q34167281 | ||
| Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers | Q34205962 | ||
| Building public trust in uses of Health Insurance Portability and Accountability Act de-identified data | Q34317668 | ||
| The Hippocratic bargain and health information technology | Q34545725 | ||
| Compelled authorizations for disclosure of health records: magnitude and implications | Q34609332 | ||
| A decade of direct-to-consumer advertising of prescription drugs | Q34663545 | ||
| Ethical and legal issues related to the use of computer programs in clinical medicine | Q39815921 | ||
| Health care information technology vendors' "hold harmless" clause: implications for patients and clinicians. | Q39992761 | ||
| Effect of drug sample removal on prescribing in a family practice clinic | Q42426725 | ||
| Biomedical data privacy: problems, perspectives, and recent advances | Q42988567 | ||
| The First Amendment and public health, at odds | Q44687615 | ||
| P433 | issue | 3 | |
| P921 | main subject | information privacy | Q456632 |
| data ethics | Q45933174 | ||
| P304 | page(s) | 256-271 | |
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | Cambridge Quarterly of Healthcare Ethics | Q5025503 |
| P1476 | title | Selling health data: de-identification, privacy, and speech | |
| P478 | volume | 24 |
| Q57778638 | Big data analytics in E-commerce: a systematic review and agenda for future research |
| Q38839077 | Consumer Health Informatics: Past, Present, and Future of a Rapidly Evolving Domain |
| Q28596745 | Data Safe Havens and Trust: Toward a Common Understanding of Trusted Research Platforms for Governing Secure and Ethical Health Research |
| Q31055051 | How Should Health Data Be Used? |
| Q54959919 | Is there a duty to participate in digital epidemiology? |
| Q38675644 | Optimizing drug development in oncology by clinical trial simulation: Why and how? |
| Q96823836 | Stigma, biomarkers, and algorithmic bias: recommendations for precision behavioral health with artificial intelligence |
| Q55475172 | The patient perspective in health care networks. |
| Q91587454 | [Between Huxley and Orwell: Big Data and Health] |
Search more.